by Ursula Tschorn | Apr 6, 2026 | Drug Pricing
German drug pricing data is among the most requested datasets in global market access. Germany is the largest pharmaceutical market in Europe, the fourth-largest worldwide, and serves as a reference price country for around 16 European countries. With statutory health...
by Ursula Tschorn | Apr 6, 2026 | Drug Pricing
A pharmaceutical data API is the most efficient way to integrate structured drug information — PZN identifiers, pricing, active ingredients, and clinical data — into your own software. Whether you are building a health-tech application, an ERP module, or a clinical...
by Ursula Tschorn | Apr 6, 2026 | Drug Pricing
German drug pricing data follows a regulated, multi-stage calculation chain that determines what manufacturers, wholesalers, pharmacies, and patients pay for prescription medicines. Unlike market-driven pricing systems in the United States, Germany uses a...
by Ursula Tschorn | Dec 18, 2025 | Drug Pricing, Drug Safety
Executive Summary: The Dual Challenge of Compliance and Strategy The global pharmaceutical landscape of 2025 is defined by a paradoxical dynamic: regulatory harmonization on one hand, and increasing market complexity on the other. For pharmaceutical professionals...
by Ursula Tschorn | Nov 27, 2025 | Drug Pricing
Executive Summary The global pharmaceutical ecosystem is currently navigating a period of unprecedented complexity. At the epicenter of this environment—balancing the rigorous demands of regulatory compliance, the clinical needs of healthcare professionals, and the...
by Ursula Tschorn | May 12, 2025 | Drug Pricing
Pharmacy wholesale drug prices in Germany are a critical concern for international pharmaceutical wholesalers looking to stay competitive and compliant. Germany is Europe’s largest pharmaceutical market, and its drug pricing system is highly regulated – making market...
